Ironwood Pharmaceuticals, Inc. (IRWD) Financials

IRWD Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 434.6 million 651.7 million
Dec. 31, 2025 396.9 million 658.7 million
Sept. 30, 2025 396.1 million 660.2 million
June 30, 2025 342.9 million 651.1 million

IRWD Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 5.1 million ?
Dec. 31, 2025 74.6 million 12.0 million
Sept. 30, 2025 47.6 million 3.6 million
June 30, 2025 -15.1 million 4.5 million

IRWD Net Income

No data available :(

IRWD Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 220.5 million 385.0 million 9.2 million
Dec. 31, 2025 215.5 million 385.0 million 9.9 million
Sept. 30, 2025 140.4 million 385.0 million 13.7 million
June 30, 2025 92.9 million 385.0 million 14.3 million

IRWD Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 166.7 million
Dec. 31, 2025 177.8 million
Sept. 30, 2025 177.8 million
June 30, 2025 161.7 million

IRWD Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 21.5 million 12.0 million -
Dec. 31, 2025 1000 21.9 million 19.3 million -
Sept. 30, 2025 2000 22.0 million 21.9 million -
June 30, 2025 2000 22.9 million 16.8 million -

IRWD Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 106.5 million 443000
Dec. 31, 2025 47.7 million 460000
Sept. 30, 2025 122.1 million 475000
June 30, 2025 85.2 million 467000

IRWD Revenue by Segment
Graph available only for paid members. Upgrade to see it.

IRWD

Price: $3.31

52 week price:
0.53
5.78

Earnings Per Share: 0.62 USD

P/E Ratio: 5.94

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 405820

Ebitda: 26.2 million

Market Capitalization: 605.8 million

Links: